Peter Hau
Impact in
- Genetics top 0.02%
- Glioma Diagnosis and Treatment
- Cancer Research top 0.2%
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer Genomics and Diagnostics
Papers in
- Genetics 106
- Glioma Diagnosis and Treatment 106
-
- TGF-β signaling in diseases 10
- Histone Deacetylase Inhibitors Research 10
- Co-authors
- Michael Weller (20 shared papers)Roger Stupp (9 shared papers)Thierry Gorlia (11 shared papers)Monika E. Hegi (5 shared papers)R.O. Mirimanoff (3 shared papers)Johan M. Kros (2 shared papers)Jacoline E. C. Bromberg (2 shared papers)Annie‐Claire Diserens (1 shared paper)
- Journals
- Journal of Clinical Oncology (26 papers)Neuro-Oncology (21 papers)Journal of Neuro-Oncology (15 papers)PLoS ONE (8 papers)Cancers (8 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Peter Hau
180 papers receiving 11.7k citations
Peter Hau's Hit Papers
Peers
Comparison fields: 5 of 137
- Genetics 6.3k
- Cancer Research 2.6k
- Oncology 2.3k
- Molecular Biology 4.3k
- Neurology 709
Countries citing papers authored by Peter Hau
This map shows the geographic impact of Peter Hau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hau more than expected).
Fields of papers citing papers by Peter Hau
This network shows the impact of papers produced by Peter Hau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hau. The network helps show where Peter Hau may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Hau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 186 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma Hit paper breakdown → | 2005 | 5292 |
| 2 | CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular Profiles Hit paper breakdown → | 2007 | 874 |
| 3 | 2010 | 335 | |
| 4 | 2010 | 291 | |
| 5 | 2004 | 284 | |
| 6 | 2008 | 232 | |
| 7 | 2008 | 203 | |
| 8 | 2014 | 193 | |
| 9 | 2020 | 191 | |
| 10 | 2016 | 175 | |
| 11 | 2004 | 162 | |
| 12 | 2005 | 144 | |
| 13 | 2001 | 122 | |
| 14 | 2008 | 111 | |
| 15 | 2009 | 105 | |
| 16 | 2009 | 101 | |
| 17 | 2013 | 93 | |
| 18 | 2012 | 88 | |
| 19 | 2007 | 86 | |
| 20 | 2009 | 84 |
About Peter Hau
Peter Hau is a scholar working on Genetics, Molecular Biology, Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 186 papers that have together received 11.8k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (106 papers), Brain Metastases and Treatment (24 papers), Cancer, Hypoxia, and Metabolism (23 papers), Cancer Cells and Metastasis (13 papers), Radiomics and Machine Learning in Medical Imaging (12 papers), TGF-β signaling in diseases (10 papers), Histone Deacetylase Inhibitors Research (10 papers) and Cell Adhesion Molecules Research (9 papers). The work is most often cited by research in Genetics (6.3k citations), Cancer Research (2.6k citations), Oncology (2.3k citations), Molecular Biology (4.3k citations) and Neurology (709 citations). Peter Hau has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Michael Weller, Roger Stupp, Thierry Gorlia, Monika E. Hegi, R.O. Mirimanoff, Johan M. Kros, Jacoline E. C. Bromberg, Annie‐Claire Diserens, Robert C. Janzer and Luigi Mariani. Their work appears in journals such as Journal of Clinical Oncology, Neuro-Oncology, Journal of Neuro-Oncology, PLoS ONE and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.